NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Gross profit

Annual gross profit:

$2.30B+$468.20M(+25.59%)
December 31, 2024

Summary

  • As of today (August 16, 2025), NBIX annual gross profit is $2.30 billion, with the most recent change of +$468.20 million (+25.59%) on December 31, 2024.
  • During the last 3 years, NBIX annual gross profit has risen by +$1.19 billion (+107.33%).
  • NBIX annual gross profit is now at all-time high.

Performance

NBIX Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

quarterly gross profit:

$676.20M+$112.80M(+20.02%)
June 30, 2025

Summary

  • As of today (August 16, 2025), NBIX quarterly gross profit is $676.20 million, with the most recent change of +$112.80 million (+20.02%) on June 30, 2025.
  • Over the past year, NBIX quarterly gross profit has increased by +$95.20 million (+16.39%).
  • NBIX quarterly gross profit is now at all-time high.

Performance

NBIX quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

TTM gross profit:

$2.47B+$95.20M(+4.01%)
June 30, 2025

Summary

  • As of today (August 16, 2025), NBIX TTM gross profit is $2.47 billion, with the most recent change of +$95.20 million (+4.01%) on June 30, 2025.
  • Over the past year, NBIX TTM gross profit has increased by +$389.00 million (+18.67%).
  • NBIX TTM gross profit is now at all-time high.

Performance

NBIX TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

NBIX Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.6%+16.4%+18.7%
3 y3 years+107.3%+81.1%+93.3%
5 y5 years+197.2%+125.4%+148.1%

NBIX Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+107.3%at high+81.1%at high+93.3%
5 y5-yearat high+197.2%at high+189.3%at high+148.1%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

NBIX Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$676.20M(+20.0%)
$2.47B(+4.0%)
Mar 2025
-
$563.40M(-8.9%)
$2.38B(+2.4%)
Dec 2024
$2.30B(+25.6%)
$618.40M(+0.7%)
$2.32B(+5.1%)
Sep 2024
-
$614.10M(+5.7%)
$2.21B(+6.1%)
Jun 2024
-
$581.00M(+14.4%)
$2.08B(+7.2%)
Mar 2024
-
$507.80M(+0.2%)
$1.94B(+5.2%)
Dec 2023
$1.83B(+26.1%)
$506.70M(+3.9%)
$1.85B(+5.9%)
Sep 2023
-
$487.60M(+10.5%)
$1.75B(+6.5%)
Jun 2023
-
$441.20M(+7.1%)
$1.64B(+4.3%)
Mar 2023
-
$411.90M(+1.9%)
$1.57B(+7.2%)
Dec 2022
$1.45B(+30.9%)
$404.30M(+5.9%)
$1.47B(+7.0%)
Sep 2022
-
$381.80M(+2.2%)
$1.37B(+7.0%)
Jun 2022
-
$373.40M(+22.0%)
$1.28B(+7.4%)
Mar 2022
-
$306.00M(-0.6%)
$1.19B(+6.5%)
Dec 2021
$1.11B(+7.9%)
$307.90M(+5.5%)
$1.12B(+6.0%)
Sep 2021
-
$291.80M(+2.1%)
$1.06B(+3.5%)
Jun 2021
-
$285.80M(+22.3%)
$1.02B(-1.4%)
Mar 2021
-
$233.70M(-4.6%)
$1.03B(-0.1%)
Dec 2020
$1.03B(+32.8%)
$245.00M(-4.2%)
$1.04B(+0.3%)
Sep 2020
-
$255.80M(-14.7%)
$1.03B(+3.6%)
Jun 2020
-
$300.00M(+27.7%)
$996.50M(+13.4%)
Mar 2020
-
$235.00M(-2.7%)
$878.40M(+12.5%)
Dec 2019
$773.21M(+73.2%)
$241.60M(+9.9%)
$780.70M(+16.7%)
Sep 2019
-
$219.90M(+20.9%)
$669.01M(+11.6%)
Jun 2019
-
$181.90M(+32.5%)
$599.31M(+16.7%)
Mar 2019
-
$137.30M(+5.7%)
$513.46M(+15.0%)
Dec 2018
$446.35M(+180.4%)
$129.91M(-13.5%)
$446.30M(+8.8%)
Sep 2018
-
$150.21M(+56.4%)
$410.15M(+28.1%)
Jun 2018
-
$96.05M(+36.9%)
$320.29M(+38.9%)
Mar 2018
-
$70.14M(-25.2%)
$230.51M(+43.7%)
Dec 2017
$159.17M(>+9900.0%)
$93.76M(+55.4%)
$160.37M(+140.7%)
Sep 2017
-
$60.34M(+861.8%)
$66.61M(+961.8%)
Jun 2017
-
$6.27M(>+9900.0%)
$6.27M(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2016
-
$0.00
$0.00
Dec 2015
$0.00(-100.0%)
-
-
Dec 2014
-$827.00K(-136.8%)
-
-
Dec 2013
$2.25M(>+9900.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2012
$0.00(-100.0%)
-
-
Dec 2011
$76.72M(+139.3%)
-
-
Sep 2011
-
$41.63M(+242.5%)
$66.30M(+69.5%)
Jun 2011
-
$12.16M(-2.8%)
$39.12M(+23.8%)
Mar 2011
-
$12.51M(-13.4%)
$31.60M(+53.5%)
Dec 2010
$32.06M(<-9900.0%)
-
-
Sep 2010
-
$14.45M(+211.2%)
$20.58M(+199.7%)
Jun 2010
-
$4.64M(+516.6%)
$6.87M(+132.1%)
Mar 2010
-
$753.00K(+1.8%)
$2.96M(+0.2%)
Dec 2009
-$226.00K(-93.8%)
$740.00K(+1.0%)
$2.95M(+33.4%)
Sep 2009
-
$733.00K(0.0%)
$2.21M(+49.5%)
Jun 2009
-
$733.00K(-1.9%)
$1.48M(+98.1%)
Mar 2009
-
$747.00K(-81.9%)
$747.00K(-95.5%)
Dec 2008
-$3.63M(-55.6%)
-
-
Dec 2007
-$8.18M(-128.5%)
-
-
Dec 2006
$28.67M(-74.8%)
-
-
Dec 2005
$113.80M(+45.7%)
-
-
Dec 2004
$78.09M(-42.3%)
-
-
Dec 2003
$135.39M(+805.8%)
-
-
Dec 2002
$14.95M(-61.3%)
-
-
Dec 2001
$38.59M(+211.5%)
-
-
Dec 2000
$12.39M(-200.1%)
$4.13M(-29.9%)
$16.79M(-3.9%)
Sep 2000
-
$5.89M(+69.2%)
$17.46M(+1.1%)
Jun 2000
-
$3.48M(+5.5%)
$17.27M(-4.1%)
Mar 2000
-
$3.30M(-31.3%)
$18.01M(-4.8%)
Dec 1999
-$12.38M(+114.7%)
$4.80M(-15.8%)
$18.91M(-0.5%)
Sep 1999
-
$5.70M(+35.4%)
$19.01M(+0.5%)
Jun 1999
-
$4.21M(+0.2%)
$18.91M(+8.7%)
Mar 1999
-
$4.20M(-14.3%)
$17.40M(-1.7%)
Dec 1998
-$5.77M(-192.2%)
$4.90M(-12.5%)
$17.70M(-8.8%)
Sep 1998
-
$5.60M(+107.4%)
$19.40M(-4.4%)
Jun 1998
-
$2.70M(-40.0%)
$20.30M(-10.6%)
Mar 1998
-
$4.50M(-31.8%)
$22.70M(-16.8%)
Dec 1997
$6.26M(-5.9%)
$6.60M(+1.5%)
$27.30M(-9.9%)
Sep 1997
-
$6.50M(+27.5%)
$30.30M(+15.2%)
Jun 1997
-
$5.10M(-44.0%)
$26.30M(-2.2%)
Mar 1997
-
$9.10M(-5.2%)
$26.90M(+33.2%)
Dec 1996
$6.65M
$9.60M(+284.0%)
$20.20M(+90.6%)
Sep 1996
-
$2.50M(-56.1%)
$10.60M(+30.9%)
Jun 1996
-
$5.70M(+137.5%)
$8.10M(+237.5%)
Mar 1996
-
$2.40M
$2.40M

FAQ

  • What is Neurocrine Biosciences, Inc. annual gross profit?
  • What is the all time high annual gross profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual gross profit year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly gross profit year-on-year change?
  • What is Neurocrine Biosciences, Inc. TTM gross profit?
  • What is the all time high TTM gross profit for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. TTM gross profit year-on-year change?

What is Neurocrine Biosciences, Inc. annual gross profit?

The current annual gross profit of NBIX is $2.30B

What is the all time high annual gross profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual gross profit is $2.30B

What is Neurocrine Biosciences, Inc. annual gross profit year-on-year change?

Over the past year, NBIX annual gross profit has changed by +$468.20M (+25.59%)

What is Neurocrine Biosciences, Inc. quarterly gross profit?

The current quarterly gross profit of NBIX is $676.20M

What is the all time high quarterly gross profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly gross profit is $676.20M

What is Neurocrine Biosciences, Inc. quarterly gross profit year-on-year change?

Over the past year, NBIX quarterly gross profit has changed by +$95.20M (+16.39%)

What is Neurocrine Biosciences, Inc. TTM gross profit?

The current TTM gross profit of NBIX is $2.47B

What is the all time high TTM gross profit for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high TTM gross profit is $2.47B

What is Neurocrine Biosciences, Inc. TTM gross profit year-on-year change?

Over the past year, NBIX TTM gross profit has changed by +$389.00M (+18.67%)
On this page